Literature DB >> 242221

Histamine H1- and H2-receptors in pulmonary and systemic vasculature of the dog.

A Tucker, E K Weir, J T Reeves, R F Grover.   

Abstract

This study was conducted to identify and clarify the actions of pulmonary and systemic H1- and H2-receptors by utilizing specific histamine receptor antagonists. Histamine was infused in anesthetized dogs during control conditions, after H2-receptor blockade with metiamide, after H1-receptor blockade with chlorpheniramine, and after combined H1- and H2-receptor blockade. Histamine infusion, alone, induced marked systemic vasodilatation, pulmonary vasoconstriction, and transient increases in cardiac output and heart rate. H2-receptor blockade prevented the systemic vasocilatation and potentiated the pulmonary vasoconstriction induced by histamine. H1-receptor blockade augmented the systemic vasodilatation, prevented the pulmonary vasoconstriction, and increased the cardiac output and heart rate responses induced by histamine. Thus, H2-receptors appear to mediate the vasocilatation, tachycardia, and increased cardiac output induced by histamine, whereas H1-receptors appear to mediate the vasoconstrictor and the minimal cardiac depressent actions of histamine. Histamine stimulates only H1- and H2-receptors, since combined H1- and H2-receptor antagonism prevented almost all of the cardiovascular actions of histamine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 242221     DOI: 10.1152/ajplegacy.1975.229.4.1008

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  23 in total

1.  H1- and H2-receptor characterization in the tracheal circulation of sheep.

Authors:  S E Webber; R O Salonen; J G Widdicombe
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

2.  Histamine-induced changes in heart rate in anaesthetized cats [proceedings].

Authors:  D A Owen
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

3.  Lung mast cells in rats exposed to acute hypoxia, and chronic hypoxia with recovery.

Authors:  A Williams; D Heath; J M Kay; P Smith
Journal:  Thorax       Date:  1977-06       Impact factor: 9.139

4.  The cardiovascular response to dimaprit, a selective histamine H2-receptor agonist.

Authors:  S B Flynn; B M Johnston; D A Owen
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

5.  Tissue blood flow and distribution of cardiac output in cats: changes caused by intravenous infusions of histamine and histamine receptor agonists.

Authors:  B M Johnston; D A Owen
Journal:  Br J Pharmacol       Date:  1977-06       Impact factor: 8.739

6.  Gastric and cardiovascular effects of histamine in the dog.

Authors:  B I Hirschowitz; J Rentz; E Molina; A L Waldo
Journal:  Agents Actions       Date:  1979-12

7.  Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis.

Authors:  Wei-Qing Rang; Yan-Hua Du; Chang-Ping Hu; Feng Ye; Gui-Shan Tan; Han-Wu Deng; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-04       Impact factor: 3.000

8.  Factors influencing lung histamine content.

Authors:  N F Voelkel; J H Newman; C M Aroyave; J T Reeves
Journal:  Agents Actions       Date:  1981-05

9.  Different mechanisms of action of histamine in isolated arteries of the dog.

Authors:  M Konishi; N Toda; M Yamamoto
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

10.  Density and ultrastructure of mast cells in lung vessels of aging rats exposed to and recovering from chronic hypoxia.

Authors:  N B Migally; A Tucker; K Greenlees; M Wright; J Zambernard
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.